Dr. Mathias Rummel, lead investigator for an important global trial in indolent and mantle cell lymphoma, presented treatment findings at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on Sunday, June 3. The results show very promising results. To read the press release, click here.